MoneyWorks4Me

Ajanta Pharma informs about record date

28 Dec 2021 Evaluate
Ajanta Pharma has informed that in accordance with Regulation 42 of Listing Regulations and Regulation 9(i) of the SEBI (Buy-Back of Securities) Regulations, 2018, the Board of Directors of the Company have fixed the record date for the proposed Buy-back offer as Friday, January 14, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..